Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,805,855
Closed -$46M 17
2025
Q3
$46M Hold
1,805,855
5.39% 9
2025
Q2
$43.8M Hold
1,805,855
5.74% 9
2025
Q1
$45.8M Hold
1,805,855
6.72% 9
2024
Q4
$47.9M Buy
1,805,855
+61,432
+4% +$1.67M 6.84% 6
2024
Q3
$50.5M Buy
1,744,423
+9,703
+0.6% +$283K 6.98% 7
2024
Q2
$48.5M Buy
1,734,720
+130,400
+8% +$3.59M 6.45% 7
2024
Q1
$44.5M Buy
1,604,320
+66,200
+4% +$1.84M 4.75% 9
2023
Q4
$44.3M Buy
1,538,120
+33,000
+2% +$998K 4.96% 8
2023
Q3
$49.9M Buy
1,505,120
+44,250
+3% +$1.56M 6.17% 4
2023
Q2
$53.6M Buy
1,460,870
+150,854
+12% +$5.87M 6.38% 4
2023
Q1
$53.4M Buy
1,310,016
+83,703
+7% +$3.62M 6.33% 5
2022
Q4
$62.8M Hold
1,226,313
7.95% 3
2022
Q3
$53.7M Hold
1,226,313
7.65% 5
2022
Q2
$64.3M Hold
1,226,313
8.51% 4
2022
Q1
$63.5M Buy
1,226,313
+14,525
+1% +$754K 7.29% 5
2021
Q4
$71.6M Sell
1,211,788
-22,004
-2% -$1.09M 8.84% 2
2021
Q3
$53.1M Hold
1,233,792
7.32% 5
2021
Q2
$48.3M Hold
1,233,792
6.94% 5
2021
Q1
$44.7M Buy
1,233,792
+29,000
+2% +$1.03M 7.11% 6
2020
Q4
$44.3M Sell
1,204,792
-57,997
-5% -$2.13M 8.18% 3
2020
Q3
$44M Buy
1,262,789
+18,972
+2% +$665K 9.98% 2
2020
Q2
$38.6M Buy
1,243,817
+188,686
+18% +$6.41M 9.72% 3
2020
Q1
$32.7M Buy
1,055,131
+140,182
+15% +$4.78M 10.92% 3
2019
Q4
$34M Buy
+914,949
New +$32.6M 11.08% 3

Other funds holding PFE

Criteria Caixa's PFE Position: Q4 2025 in Review

Criteria Caixa sold out of Pfizer (PFE) in Q4 2025, closing a stake of 1,805,855 shares — an estimated $46M sold.

Criteria Caixa first reported a position in PFE in Q4 2019 and held it in 24 quarters. The position peaked at $71.6M in Q4 2021. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Criteria Caixa reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Criteria Caixa sold 1,805,855 Pfizer shares in Q4 2025, an estimated $46M.
  • Criteria Caixa first reported a position in Pfizer in Q4 2019 and held it in 24 quarters.
  • Criteria Caixa's Pfizer position peaked at $71.6M in Q4 2021.
  • 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Criteria Caixa's 13F filing for Q4 2025, filed 17 Feb 2026.